Pre-treatment antibodies to infliximab and adalimumab are common but are not associated with anti-TNF treatment failure

被引：0
|
作者：
Nice, R. [1 ,2 ]
Goodhand, J. R. [2 ,3 ]
Kennedy, N. [2 ,3 ]
Ahmad, T. [2 ]
Winyard, P. [2 ]
McDonald, T. J. [1 ,2 ]
机构：
[1] Royal Devon & Exeter NHS Fdn Trust, Blood Sci, Exeter, Devon, England
[2] Univ Exeter, Med Sch, Exeter, Devon, England
[3] Royal Devon & Exeter NHS Fdn Trust, Gastroenterol, Exeter, Devon, England
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P196
引用
收藏
页码：I256 / I256
页数：1
相关论文
共 50 条
  • [1] Autoimmune Tumefactive Rhombencephalitis Associated with Anti-TNFα (Adalimumab) Treatment
    Mahajan, Kedar
    Shah, Omar
    NEUROLOGY, 2016, 86
  • [2] Immunosuppressive co-treatment with infliximab and adalimumab is not superior to anti-TNF monotherapy to prevent treatment failure and treatment discontinuation in ulcerative colitis
    Vieujean, S.
    Louis, E.
    Reenaers, C.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S418 - S419
  • [3] Adalimumab: an anti-TNF agent for the treatment of psoriatic arthritis
    Mease, PJ
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (11) : 1491 - 1504
  • [4] Tuberculosis after initiation of anti-TNF α treatment with Infliximab
    Antoni, C
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2002, 61 (04): : 464 - 465
  • [5] Characteristics of tuberculosis during anti-tnf treatment in RA patients in the Netherlands and the influence of pre-treatment screening and treatment
    den Broeder, AA
    Vonkeman, H
    Creemers, MCW
    de Jong, E
    van de Laar, MA
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S342 - S343
  • [6] Characteristics of tuberculosis during anti-TNF treatment in RA patients in the netherlands and influence of pre-treatment screening and treatment
    Den Broeder, AA
    Vonkeman, H
    Creemers, MCW
    De Jong, E
    Van de Laar, MA
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 82 - 82
  • [7] INFLUENCE OF IMMUNOGENICITY OF ANTI-TNF THERAPY IN RA PATIENTS WITH A LONG-TERM TREATMENT WITH INFLIXIMAB OR ADALIMUMAB
    Villalba, A.
    Plasencia, C.
    Peiteado, D.
    Nuno, L.
    Bonilla, G.
    Lojo, L.
    Pascual, D.
    del Moral, R.
    Lopez Casla, M. T.
    Balsa, A.
    Martin Mola, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 221 - 221
  • [8] Treatment of Kawasaki disease with anti-TNF antibodies
    Levin, Michael
    Burgner, David
    LANCET, 2014, 383 (9930): : 1700 - 1703
  • [9] Alternative for Anti-TNF Antibodies for Arthritis Treatment
    Paquet, Joseph
    Henrionnet, Christel
    Pinzano, Astrid
    Vincourt, Jean-Baptiste
    Gillet, Pierre
    Netter, Patrick
    Chary-Valckenaere, Isabelle
    Loeuille, Damien
    Pourel, Jacques
    Grossin, Laurent
    MOLECULAR THERAPY, 2011, 19 (10) : 1887 - 1895
  • [10] Bronchospasm associated with anti-TNF treatment
    Dubey, S.
    Kerrigan, N.
    Mills, K.
    Scott, D. G.
    CLINICAL RHEUMATOLOGY, 2009, 28 (08) : 989 - 992
12345